BridgeBio Pharma, Inc. (BBIO)
81.05
-0.45
(-0.55%)
USD |
NASDAQ |
Aug 24, 16:00
80.04
-1.01
(-1.25%)
After-Hours: 19:59
BridgeBio Pharma Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2021 | 125.42 |
| March 29, 2021 | 121.14 |
| March 26, 2021 | 129.03 |
| March 25, 2021 | 133.95 |
| March 24, 2021 | 129.99 |
| March 23, 2021 | 139.57 |
| March 22, 2021 | 146.62 |
| March 19, 2021 | 143.54 |
| March 18, 2021 | 134.65 |
| March 17, 2021 | 145.58 |
| March 16, 2021 | 144.37 |
| March 15, 2021 | 148.27 |
| March 12, 2021 | 150.50 |
| March 11, 2021 | 151.09 |
| March 10, 2021 | 147.91 |
| March 09, 2021 | 137.69 |
| March 08, 2021 | 126.19 |
| March 05, 2021 | 132.00 |
| March 04, 2021 | 132.64 |
| March 03, 2021 | 135.57 |
| March 02, 2021 | 140.38 |
| March 01, 2021 | 152.56 |
| February 26, 2021 | 149.95 |
| February 25, 2021 | 138.17 |
| February 24, 2021 | 143.01 |
| Date | Value |
|---|---|
| February 23, 2021 | 139.89 |
| February 22, 2021 | 139.32 |
| February 19, 2021 | 141.46 |
| February 18, 2021 | 135.46 |
| February 17, 2021 | 137.30 |
| February 16, 2021 | 137.86 |
| February 12, 2021 | 142.91 |
| February 11, 2021 | 142.71 |
| February 10, 2021 | 146.11 |
| February 09, 2021 | 150.31 |
| February 08, 2021 | 153.49 |
| February 05, 2021 | 144.86 |
| February 04, 2021 | 136.86 |
| February 03, 2021 | 133.61 |
| February 02, 2021 | 133.68 |
| February 01, 2021 | 121.84 |
| January 29, 2021 | 120.42 |
| January 28, 2021 | 119.44 |
| January 27, 2021 | 117.68 |
| January 26, 2021 | 132.23 |
| January 25, 2021 | 139.57 |
| January 22, 2021 | 147.40 |
| January 21, 2021 | 140.95 |
| January 20, 2021 | 143.65 |
| January 19, 2021 | 147.19 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| Ionis Pharmaceuticals, Inc. | 23.36 |
| Pfizer Inc. | 1.872 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
| BioMarin Pharmaceutical, Inc. | 1.991 |
Price to Book Value Related Metrics
| PS Ratio | 22.05 |
| Price | 81.05 |
| Earnings Yield | -4.40% |
| Market Cap | 15.83B |